BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33407866)

  • 1. Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis.
    Fox DA; Lundy SK; Whitfield ML; Berrocal V; Campbell P; Rasmussen S; Ohara R; Stinson A; Gurrea-Rubio M; Wiewiora E; Spino C; Bush E; Furst D; Pillai S; Khanna D
    Arthritis Res Ther; 2021 Jan; 23(1):10. PubMed ID: 33407866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
    Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment].
    Ma XB; Zhang XW; Jia RL; Gao Y; Liu HJ; Liu YF; Li YN
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):721-727. PubMed ID: 34393235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis.
    Tsuji-Yamada J; Nakazawa M; Minami M; Sasaki T
    J Rheumatol; 2001 Jun; 28(6):1252-8. PubMed ID: 11409116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
    Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
    Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
    Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
    Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
    Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
    Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
    Jiang N; Li M; Zeng X
    Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of lymphocyte subpopulations in systemic sclerosis.
    Ercole LP; Malvezzi M; Boaretti AC; Utiyama SR; Rachid A
    J Investig Allergol Clin Immunol; 2003; 13(2):87-93. PubMed ID: 12968391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.
    Fujii H; Hasegawa M; Takehara K; Mukaida N; Sato S
    Clin Exp Immunol; 2002 Dec; 130(3):548-56. PubMed ID: 12452848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
    MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
    J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.
    Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D
    Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune profiling analysis of double-negative T cells in patients with systemic sclerosis.
    Zhang D; Alip M; Chen H; Wu D; Zhu H; Han Y; Yuan X; Feng X; Sun L; Wang D
    Clin Rheumatol; 2024 May; 43(5):1623-1634. PubMed ID: 38436769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in peripheral T- and B-cell subsets in patients with systemic sclerosis.
    Wu J; Zhang X; Lin S; Wei Q; Lin Z; Jin O; Gu J
    Int J Rheum Dis; 2024 Apr; 27(4):e15145. PubMed ID: 38661314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.
    Krasimirova E; Velikova T; Ivanova-Todorova E; Tumangelova-Yuzeir K; Kalinova D; Boyadzhieva V; Stoilov N; Yoneva T; Rashkov R; Kyurkchiev D
    World J Exp Med; 2017 Aug; 7(3):84-96. PubMed ID: 28890870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients.
    Guggino G; Lo Pizzo M; Di Liberto D; Rizzo A; Cipriani P; Ruscitti P; Candore G; Gambino CM; Sireci G; Dieli F; Giacomelli R; Triolo G; Ciccia F
    Clin Exp Immunol; 2017 Nov; 190(2):208-216. PubMed ID: 28681919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered B lymphocyte homeostasis and functions in systemic sclerosis.
    Forestier A; Guerrier T; Jouvray M; Giovannelli J; Lefèvre G; Sobanski V; Hauspie C; Hachulla E; Hatron PY; Zéphir H; Vermersch P; Labalette M; Launay D; Dubucquoi S
    Autoimmun Rev; 2018 Mar; 17(3):244-255. PubMed ID: 29343447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.
    Truchetet ME; Brembilla NC; Montanari E; Allanore Y; Chizzolini C
    Arthritis Res Ther; 2011; 13(5):R166. PubMed ID: 21996293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib.
    Ricard L; Jachiet V; Malard F; Ye Y; Stocker N; Rivière S; Senet P; Monfort JB; Fain O; Mohty M; Gaugler B; Mekinian A
    Ann Rheum Dis; 2019 Apr; 78(4):539-550. PubMed ID: 30760472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.